Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761513018 | HER2 (Human epidermal growth factor receptor 2) inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3761514012 | Human epidermal growth factor receptor 2 inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3761515013 | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Is a | Substance with protein-tyrosine kinase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Has disposition | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Is a | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trastuzumab | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Pertuzumab | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Trastuzumab emtansine | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Trastuzumab deruxtecan | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Margetuximab | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Receptor tyrosine-protein kinase erbB-2 inhibitor therapy | Direct substance | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
| Lapatinib | Is a | True | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Tucatinib | Is a | False | Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR